Furthermore, recent studies demonstrated that over-expression of microRNAs, such as miR181 and miR421, may be involved in ATM down-regulation in breast cancer (Fang et al. 2010; Bueno et al. 2014). This evidence concerns the gene ATM and breast cancer.